data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Mesoblast
(NASDAQ:MESO)
$3.69
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$3.62
-0.0700[-1.90%]
After Hours: 4:26PM EDT
Day Range- - -52 Wk Range2.14 - 6.77Open / Close- / -Float / Outstanding- / 147.3M
Vol / Avg.- / 70.4KMkt Cap543.6MP/E-50d Avg. Price3.06
Div / Yield-Payout Ratio-Total Float-EPS-0.16

Mesoblast Stock (NASDAQ:MESO), Quotes and News Summary

Mesoblast Stock (NASDAQ: MESO) stock price, news, charts, stock research, profile.

Day Range- - -52 Wk Range2.14 - 6.77Open / Close- / -Float / Outstanding- / 147.3M
Vol / Avg.- / 70.4KMkt Cap543.6MP/E-50d Avg. Price3.06
Div / Yield-Payout Ratio-Total Float-EPS-0.16
Globe Newswire - Nov 22, 2022, 6:32PM
Globe Newswire - Nov 22, 2022, 6:00PM
Globe Newswire - Nov 21, 2022, 6:00AM
Globe Newswire - Oct 30, 2022, 7:50PM
News Direct - Oct 14, 2022, 8:00AM
Globe Newswire - Oct 2, 2022, 7:51PM
Globe Newswire - Aug 30, 2022, 7:05PM
Globe Newswire - Aug 29, 2022, 8:14PM
Globe Newswire - Aug 18, 2022, 7:00AM
Globe Newswire - Jul 29, 2022, 7:05AM
Globe Newswire - Jul 11, 2022, 8:40PM
Globe Newswire - Jun 9, 2022, 7:00AM
Globe Newswire - May 31, 2022, 8:15PM
Globe Newswire - May 23, 2022, 9:00AM
Globe Newswire - Apr 28, 2022, 8:35PM
PRNewswire - Mar 31, 2022, 8:45AM
Globe Newswire - Mar 23, 2022, 8:40PM
Globe Newswire - Feb 24, 2022, 5:30PM
Globe Newswire - Feb 24, 2022, 5:57AM
Globe Newswire - Feb 20, 2022, 6:19PM
Globe Newswire - Feb 1, 2022, 7:20PM
Globe Newswire - Jan 30, 2022, 7:16PM
Globe Newswire - Jan 24, 2022, 6:45PM
Globe Newswire - Jan 11, 2022, 8:26PM
PRNewswire - Jan 5, 2022, 8:55AM
Globe Newswire - Dec 30, 2021, 6:38PM
PRNewswire - Dec 16, 2021, 9:31AM
Globe Newswire - Dec 15, 2021, 7:09PM
PRNewswire - Dec 15, 2021, 8:30AM
Globe Newswire - Dec 13, 2021, 7:18PM
Globe Newswire - Dec 5, 2021, 6:47PM
InvestorsObserver - 1 day ago
InvestorsObserver - Nov 23, 2022, 1:28PM
Seeking Alpha - Nov 23, 2022, 8:50AM
TipRanks - Nov 23, 2022, 7:25AM
Seeking Alpha - Oct 31, 2022, 10:27AM
TipRanks - Sep 2, 2022, 7:21AM
TipRanks - Aug 31, 2022, 8:13AM
Seeking Alpha - Aug 30, 2022, 10:28PM
InvestorsObserver - Jul 29, 2022, 12:58PM
TipRanks - Jul 20, 2022, 3:55PM
InvestorsObserver - Jul 19, 2022, 6:48AM
InvestorsObserver - Jul 1, 2022, 10:15AM
TipRanks - Jun 22, 2022, 6:46AM
InvestorsObserver - Jun 21, 2022, 10:06AM
InvestorsObserver - Jun 17, 2022, 11:40AM
InvestorsObserver - Jun 14, 2022, 1:18PM
TipRanks - Jun 8, 2022, 5:05AM
TipRanks - Jun 3, 2022, 8:15AM
TipRanks - Jun 1, 2022, 6:25AM
InvestorsObserver - Mar 9, 2022, 8:57AM
TipRanks - Mar 3, 2022, 7:36AM
TipRanks - Mar 1, 2022, 4:04AM
TipRanks - Feb 28, 2022, 6:28AM
TipRanks - Feb 27, 2022, 5:57AM
TipRanks - Feb 6, 2022, 11:38AM
Seeking Alpha - Feb 2, 2022, 12:48AM
Seeking Alpha - Jan 20, 2022, 2:34PM
Seeking Alpha - Jan 12, 2022, 2:07AM
Seeking Alpha - Dec 31, 2021, 9:22AM
Seeking Alpha - Dec 16, 2021, 4:34AM
InvestorsObserver - Dec 15, 2021, 6:10AM
InvestorsObserver - Dec 14, 2021, 12:24PM
Seeking Alpha - Dec 14, 2021, 6:02AM
Sector: Health Care.Industry: Biotechnology
Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.
Read More

Earnings

see more
Q2 2023Est.ActualSurprise
EPS
(EXPECTED)2023-02-23
REV
Q1 2023Est.ActualSurprise
EPS-0.160-0.120 0.0400
REV3.470M1.503M-1.967M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Mesoblast (MESO) stock?

A

You can purchase shares of Mesoblast (NASDAQ: MESO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Mesoblast's (MESO) competitors?

Q

What is the target price for Mesoblast (MESO) stock?

A

The latest price target for Mesoblast (NASDAQ: MESO) was reported by Piper Sandler on Tuesday, September 6, 2022. The analyst firm set a price target for 7.00 expecting MESO to rise to within 12 months (a possible 89.70% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Mesoblast (MESO)?

A

The stock price for Mesoblast (NASDAQ: MESO) is $3.69 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Mesoblast (MESO) pay a dividend?

A

There are no upcoming dividends for Mesoblast.

Q

When is Mesoblast (NASDAQ:MESO) reporting earnings?

A

Mesoblast’s Q2 earnings are confirmed for Thursday, February 23, 2023.

Q

Is Mesoblast (MESO) going to split?

A

There is no upcoming split for Mesoblast.

Q

What sector and industry does Mesoblast (MESO) operate in?

A

Mesoblast is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.